- Interstitial Lung Disease Associated with Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil, and Leucovorin
-
Park S, Jung JJ, Kim GB, Yoon HS, Ko SH, Ko JE, Lee YS
- KMID: 1718341
- Korean J Gastroenterol.
- 2010 May;55(5):340-343.
- doi: 10.4166/kjg.2010.55.5.340
Oxaliplatin with 5-fluorouracil plus leucovorin (FOLFOX) has become the standard treatment in patients with colorectal cancer. Among known toxicities induced by oxaliplatin, hematological, gastrointestinal and neurological toxicities are common. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Pharmacoethnicity in the Development of Cytotoxic and Molecular Targeted Drugs in Oncology
-
Saijo N
- KMID: 1776911
- Yonsei Med J.
- 2013 Jan;54(1):1-14.
- doi: 10.3349/ymj.2013.54.1.1
The effective and toxic ranges of anticancer drugs are very narrow and, in some cases, inverted. Thus determination of the most appropriate dosage and schedule of administration is crucial for... -
- CITED
-
- Close
- SHARE
-
- Close
- Toxic Inhalational Injury-Associated Interstitial Lung Disease in Children
-
Lee E, Seo JH, Kim HY, Yu J, Jhang WK, Park SJ, Kwon JW, Kim BJ, Do KH, Cho YA, Kim SA, Jang SJ, Hong SJ
- KMID: 2158041
- J Korean Med Sci.
- 2013 Jun;28(6):915-923.
- doi: 10.3346/jkms.2013.28.6.915
Interstitial lung disease in children (chILD) is a group of disorders characterized by lung inflammation and interstitial fibrosis. In the past recent years, we noted an outbreak of child in... -
- CITED
-
- Close
- SHARE
-
- Close
